Sun Pharma Says U.S. Unit Gets Subpoena in Antitrust Probe

Sun Pharmaceutical Industries Ltd., India's largest drugmaker, said its U.S. unit received a grand jury subpoena from the Justice Department's antitrust division related to generic products and pricing. The summons also sought documents about communications with competitors and others regarding the sale of generic drugs, along with corporate and employee records, Sun Pharma said in a May 27 stock exchange filing.